These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36396817)

  • 1. Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis.
    Wu Z; Yao T; Wang Z; Liu B; Wu N; Lu M; Shen N
    Br J Cancer; 2023 Jan; 128(2):168-176. PubMed ID: 36396817
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Anderson JL; Knowlton KU; Muhlestein JB; Bair TL; Le VT; Horne BD
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):321-327. PubMed ID: 33514290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis.
    Batais M; Almigbal T; Alotaibi K; Alodhayani A; Alkhushail A; Altheaby A; Alhantoushi M; Alsaad S; Dalbhi SA; Alghamdi Y
    Medicine (Baltimore); 2021 Apr; 100(17):e25714. PubMed ID: 33907158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer: A Nationwide Nested Case-Control Study.
    Kristensen KB; Hicks B; Azoulay L; Pottegård A
    Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e006687. PubMed ID: 33435729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.
    Lo KB; Bhargav R; Salacup G; Pelayo J; Albano J; McCullough PA; Rangaswami J
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):919-930. PubMed ID: 32945216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.
    Hicks BM; Filion KB; Yin H; Sakr L; Udell JA; Azoulay L
    BMJ; 2018 Oct; 363():k4209. PubMed ID: 30355745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.
    Dai YN; Wang JH; Zhu JZ; Lin JQ; Yu CH; Li YM
    Cancer Causes Control; 2015 Sep; 26(9):1245-55. PubMed ID: 26081426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    Xie Q; Tang S; Li Y
    Ann Palliat Med; 2022 Apr; 11(4):1253-1263. PubMed ID: 34775774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
    Zhang L; Zeng X; Fu P; Wu HM
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
    Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
    Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
    Nardone B; Majewski S; Kim AS; Kiguradze T; Martinez-Escala EM; Friedland R; Amin A; Laumann AE; Edwards BJ; Rademaker AW; Martini MC; West DP
    Drug Saf; 2017 Mar; 40(3):249-255. PubMed ID: 27943160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
    Hallas J; Christensen R; Andersen M; Friis S; Bjerrum L
    Br J Clin Pharmacol; 2012 Jul; 74(1):180-8. PubMed ID: 22243442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.